C

Chiome Bioscience Inc
TSE:4583

Watchlist Manager
Chiome Bioscience Inc
TSE:4583
Watchlist
Price: 259 JPY 1.57% Market Closed
Market Cap: 16.6B JPY
Have any thoughts about
Chiome Bioscience Inc?
Write Note

Chiome Bioscience Inc
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chiome Bioscience Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
C
Chiome Bioscience Inc
TSE:4583
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Other
ÂĄ34m
CAGR 3-Years
-68%
CAGR 5-Years
-66%
CAGR 10-Years
N/A
Medinet Co Ltd
TSE:2370
Other
-ÂĄ1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
41%
CellSource Co Ltd
TSE:4880
Other
-ÂĄ6m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Other
-ÂĄ1k
CAGR 3-Years
0%
CAGR 5-Years
24%
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Chiome Bioscience Inc
Glance View

Market Cap
15.9B JPY
Industry
Life Sciences Tools & Services

Chiome Bioscience, Inc. engages in the development and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) system. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 37 full-time employees. The company went IPO on 2011-12-20. The firm operates in two business segments. The Drug Discovery segment is engaged in the research and development of specific antibodies based on new antigens and mechanisms and licensing to pharmaceutical companies. The Drug Discovery Support segment is engaged in development of lead antibodies for therapeutic drugs in collaborating with pharmaceutical companies in Japan and overseas.

Intrinsic Value
31.11 JPY
Overvaluation 88%
Intrinsic Value
Price
C

See Also

Back to Top